Source: FinanzNachrichten

C-Cure: Invetech and Celyad SA Announce Collaboration to Realize the Commercial cGMP Production of C-Cure®

Invetech to design and supply automated production systems for commercialization of autologous cell therapy based on Celyad's cardiopoiesis technology platform SAN DIEGO, Feb. 3, 2016 /PRNewswire/...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more